Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04725331
Title A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Transgene

Merkel cell carcinoma

lung non-small cell carcinoma

triple-receptor negative breast cancer



Advanced Solid Tumor

non-Hodgkin lymphoma



BT-001 + Pembrolizumab

Age Groups: senior | adult
Covered Countries

Facility Status City State Zip Country Details
Clinique Universitaire Saint-Luc Recruiting Brussels 1200 Belgium Details
Institut Bergonié Recruiting Bordeaux 33000 France Details
Centre Léon Bérard Recruiting Lyon 69008 France Details
Hôpital Saint-Louis AP-HP Recruiting Paris 75010 France Details
Institut Gustave Roussy Recruiting Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from for the field